| Ab01691-23.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-21.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-11.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-12.1
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-12.1-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-44.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-45.1-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-15.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-49.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-200.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-16.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-48.1-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-16.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-23.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-3.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-10.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-45.1
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-15.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-49.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-48.1
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-44.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-47.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-3.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-10.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-21.0-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 500 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-200.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-47.0
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-10.3-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-10.7
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-1.7
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-46.0-ISS
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 100 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-46.0-IST
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 50 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-3.3
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-10.6
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-10.7-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-1.6-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-10.6-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-10.3
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-1.6
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 200 ug
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-3.3-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| Ab01691-1.7-BT
| Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]
| 1 mg
| Absolute Antibody
| ELISA; IF
|
|
| Other
| Request Quotation
| Request
|
| orb1671551
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Rabbit IgG
| 0.2 mg
| Biorbyt
| ELISA, IF
| Clonality.RE
|
| Virus
| Request Quotation
| Request
|
| orb1671553
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Human IgM
| 0.05 mg
| Biorbyt
| ELISA, IF
| Clonality.RE
|
| Virus
| Request Quotation
| Request
|
| orb1671554
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Human IgG1
| 0.2 mg
| Biorbyt
| ELISA, IF
| Clonality.RE
|
| Virus
| Request Quotation
| Request
|
| orb1671552
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Human IgA1
| 0.05 mg
| Biorbyt
| ELISA, IF
| Clonality.RE
|
| Virus
| Request Quotation
| Request
|
| LS-C829884
| SARS-CoV + CoV-2 Nucleoprotein Antibody (clone CR3009 (03-009)) LS-C829884
| 0.2 mg
| LSBio
|
|
|
|
| Request Quotation
| Request
|
| LS-C829883
| SARS-CoV + CoV-2 Nucleoprotein Antibody (clone CR3009 (03-009)) LS-C829883
| 0.2 mg
| LSBio
|
|
|
|
| Request Quotation
| Request
|
| 24-829
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Human IgG1
| 0.2 mg
| ProSci
| ELISA,IF
| Recombinant
|
| Virus
| Request Quotation
| Request
|
| 24-830
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Human IgM
| 0.05 mg
| ProSci
| ELISA,IF
| Recombinant
|
| Virus
| Request Quotation
| Request
|
| 24-832
| Covid-19 & SARS-CoV Nucleoprotein Antibody [CR3009 (03-009)], Rabbit IgG
| 0.2 mg
| ProSci
| ELISA,IF
| Recombinant
|
| Virus
| Request Quotation
| Request
|